Anasonic has achieved significant milestones since its inception, reflecting our dedication to innovation and excellence in medical device development.
• 2018.12.05: Anasonic established (formerly Sonotiex)
• 2020.11.05: Partnership with Seoul St. Mary’s Hospital for glomerular filtration rate (GFR) regulation
• 2021.08.10: Recognition of corporate research lab
• 2021.11.24: Certification as a venture business (innovation growth type)
• 2022.04.01: Certification as a small business
• 2023.01.17: Patent registration for ultrasound-based device and method
• 2023.11.10: Medical device manufacturing permit (KFDA)
• 2024.03.21: GMP certification for medical devices (Korea Testing & Research Institute)
• 2024.04.01: Medical device approval (class 2 ultrasound stimulator) (Korea Medical Device Information and Technology Assistance Center)
• 2024.09: Expected exploratory clinical trials for kidney function improvement in CKD patients (Seoul St. Mary’s Hospital)